Biểu đồ giá cổ phiếu RGC
RGC Cổ tức
Regencell Bioscience Holdings Ltd
$6.09
-1.61%
$-0.1
Khi đóng cửa: Jun 30, 16:00:00 GMT-4
$6.29
3.44%
$0.2
Phiên trước giờ: Jul 01, 07:45:41 GMT-4
Quay lại
Regencell Bioscience Holdings Ltd (RGC) Cổ tức
Thống kê chính
Giá đóng cửa trước
$6.19
Giá mở cửa
$6.15
Phạm vi ngày
$5.8 - $6.88
Phạm vi 52 tuần
$5.8 - $69
Khối lượng
434.1K
Khối lượng trung bình
146.3K
Tỷ suất cổ tức
--
EPS (TTM)
-0.01
Vốn hóa thị trường
$3.1B
RGC là gì?
Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company employs 10 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
